research peptide tirzepatide 10mg — Dual Receptor Agonist (GLP-1/GIP) — Peptid – Prime Labs Tirzepatide Peptide (GLP2-T) | NextDay

This glucose-dependent mechanism is why the drugs carry a much lower risk of dangerously low blood sugar compared to older diabetes medications

Wegovy is specifically FDA-approved for chronic weight management in adults and adolescents aged 12 years and older with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity (e.g., hypertension, type 2 diabetes, dyslipidemia) [8] [9]

Psychiatry 48 , 766777 (2000)

Results were promising, with those taking 5-mg, 10-mg, and 15-mg weekly injections of tirzepatide losing weight, and those on the highest dose losing 22.9 percent of their body weight on average

A 2.5 mg dose is 0.25 mL